investordatabase.org

Panakes Partners

panakes.it Direct investor

Panakes Partners is an independent venture capital firm based in Milan, Italy, focused on investing in early-stage life sciences companies across Europe and globally. The firm provides financial and business support to entrepreneurs developing innovative medical technologies and therapies.

Panakes Partners is a venture capital firm headquartered in Milan, Italy. It invests directly in companies, from seed to Series A, in life Sciences, biotech, medical Devices and therapeutics.

“We invest in ambitious early stage start-ups and SMEs with innovative products globally, mainly across Europe.”

Panakes Partners, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedSeries A
Headquarters
Milan, Italy
Invests in
Europe, global
Sectors
Life Sciences, Biotech, Medical Devices, Therapeutics, Diagnostics, Cardiovascular, Oncology, Neuromodulation

Team, as Panakes Partners publishes it

  • Fabrizio Landi Founder and Managing Partner
  • Alessio Beverina Founder and Managing Partner
  • Diana Saraceni Founder and Managing Partner
  • Barbara Castellano Partner
  • Rob Woodman Partner
  • Marco Sardina Scientific Partner
  • Alessio Piuma Principal
  • Andrea Ballerini Investment Manager
  • Giacomo Piccinini Investment Manager
  • Annalisa Coraducci Senior Analyst
  • Lorenzo Giordano CFO
  • Paola Crovato Office and Deal Flow Manager

Names and roles exactly as listed on panakes.it. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 3 co-investors found.

Where this comes from

Every fact above was read from a page Panakes Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 553 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under